Results 371 to 380 of about 6,664,068 (391)
Some of the next articles are maybe not open access.

Community-acquired Pneumonia and Hospital-acquired Pneumonia

Medical Clinics of North America, 2019
Pneumonia is among the leading causes of morbidity and mortality worldwide. Although Streptococcus pneumoniae is the most likely cause in most cases, the variety of potential pathogens can make choosing a management strategy a complex endeavor. The setting in which pneumonia is acquired heavily influences diagnostic and therapeutic choices. Because the
David W. Hsia   +2 more
openaire   +3 more sources

To Merge or to Acquire

2012
Driven by cross-border mergers and acquisitions (M&As)1 and the internationalization of production in a range of industries, foreign direct investment (FDI) has risen significantly since 1980 (see Table 1.1). Among the major players are the European Union (EU) and North America, which represent roughly two-thirds of FDI stock, approximately 60 percent ...
Aristidis Bitzenis, Vasileios A. Vlachos
openaire   +2 more sources

Community acquired pneumonia.

Clinical evidence, 2002
In the northern hemisphere about 12/1000 people a year (on average) contract pneumonia while living in the community, with most cases caused by Streptococcus pneumoniae. Mortality ranges from about 5% to 35% depending on severity of disease, with a worse prognosis in older people, men, and people with chronic diseases.We conducted a systematic review ...
openaire   +9 more sources

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

The Lancet, 2005
E. Baxter   +12 more
semanticscholar   +1 more source

Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion

Nature Reviews. Cancer, 2019
José Pedro Friedmann Angeli   +2 more
semanticscholar   +1 more source

Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.

Journal of the American Medical Association (JAMA), 2020
G. Olson, A. Davis
semanticscholar   +1 more source

De-novo and acquired resistance to immune checkpoint targeting.

The Lancet Oncology, 2017
N. Syn, M. Teng, T. Mok, R. Soo
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy